PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration

BACKGROUND: Continuous hemodiafiltration (CHDF) is used as renal replacement therapy for critically ill patients with renal failure, and to treat hypercytokinemia. Since CHDF also clears therapeutic agents, drug pharmacokinetics (PK) should be dependent upon CHDF conditions. Although the antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Akashita, Gaku, Hosaka, Yuto, Noda, Toru, Isoda, Kazuya, Shimada, Tsutomu, Sawamoto, Kazuki, Miyamoto, Ken-ichi, Taniguchi, Takumi, Sai, Yoshimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728804/
https://www.ncbi.nlm.nih.gov/pubmed/26819742
http://dx.doi.org/10.1186/s40780-015-0031-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728804/
https://www.ncbi.nlm.nih.gov/pubmed/26819742
http://dx.doi.org/10.1186/s40780-015-0031-6

Ejemplares similares